The micro(nano)plastics perspective: exploring cancer development and therapy
Abstract Microplastics, as an emerging environmental pollutant, have received widespread attention for their potential impact on ecosystems and human health. Microplastics are defined as plastic particles less than 5 millimeters in diameter and can be categorized as primary and secondary microplasti...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Molecular Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12943-025-02230-z |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832585966651441152 |
---|---|
author | Xiangying Deng Yajun Gui Lin Zhao |
author_facet | Xiangying Deng Yajun Gui Lin Zhao |
author_sort | Xiangying Deng |
collection | DOAJ |
description | Abstract Microplastics, as an emerging environmental pollutant, have received widespread attention for their potential impact on ecosystems and human health. Microplastics are defined as plastic particles less than 5 millimeters in diameter and can be categorized as primary and secondary microplastics. Primary microplastics usually originate directly from industrial production, while secondary microplastics are formed by the degradation of larger plastic items. Microplastics are capable of triggering cytotoxicity and chronic inflammation, and may promote cancer through mechanisms such as pro-inflammatory responses, oxidative stress and endocrine disruption. In addition, improved microplastics bring new perspectives to cancer therapy, and studies of microplastics as drug carriers are underway, showing potential for high targeting and bioavailability. Although current studies suggest an association between microplastics and certain cancers (e.g., lung, liver, and breast cancers), the long-term effects and specific mechanisms still need to be studied. This review aimed at exploring the carcinogenicity of microplastics and their promising applications in cancer therapy provides important directions for future research and emphasizes the need for multidisciplinary collaboration to address this global health challenge. |
format | Article |
id | doaj-art-13b6cfba79bb417f9906695585fd6b97 |
institution | Kabale University |
issn | 1476-4598 |
language | English |
publishDate | 2025-01-01 |
publisher | BMC |
record_format | Article |
series | Molecular Cancer |
spelling | doaj-art-13b6cfba79bb417f9906695585fd6b972025-01-26T12:18:15ZengBMCMolecular Cancer1476-45982025-01-0124111410.1186/s12943-025-02230-zThe micro(nano)plastics perspective: exploring cancer development and therapyXiangying Deng0Yajun Gui1Lin Zhao2Department of Pathology, The Second Xiangya Hospital, Central South UniversityDepartment of Pathology, The Second Xiangya Hospital, Central South UniversityDepartment of Pathology, The Second Xiangya Hospital, Central South UniversityAbstract Microplastics, as an emerging environmental pollutant, have received widespread attention for their potential impact on ecosystems and human health. Microplastics are defined as plastic particles less than 5 millimeters in diameter and can be categorized as primary and secondary microplastics. Primary microplastics usually originate directly from industrial production, while secondary microplastics are formed by the degradation of larger plastic items. Microplastics are capable of triggering cytotoxicity and chronic inflammation, and may promote cancer through mechanisms such as pro-inflammatory responses, oxidative stress and endocrine disruption. In addition, improved microplastics bring new perspectives to cancer therapy, and studies of microplastics as drug carriers are underway, showing potential for high targeting and bioavailability. Although current studies suggest an association between microplastics and certain cancers (e.g., lung, liver, and breast cancers), the long-term effects and specific mechanisms still need to be studied. This review aimed at exploring the carcinogenicity of microplastics and their promising applications in cancer therapy provides important directions for future research and emphasizes the need for multidisciplinary collaboration to address this global health challenge.https://doi.org/10.1186/s12943-025-02230-zMicro (nano) plasticsCarcinogenicityDrug carrierCancer therapy |
spellingShingle | Xiangying Deng Yajun Gui Lin Zhao The micro(nano)plastics perspective: exploring cancer development and therapy Molecular Cancer Micro (nano) plastics Carcinogenicity Drug carrier Cancer therapy |
title | The micro(nano)plastics perspective: exploring cancer development and therapy |
title_full | The micro(nano)plastics perspective: exploring cancer development and therapy |
title_fullStr | The micro(nano)plastics perspective: exploring cancer development and therapy |
title_full_unstemmed | The micro(nano)plastics perspective: exploring cancer development and therapy |
title_short | The micro(nano)plastics perspective: exploring cancer development and therapy |
title_sort | micro nano plastics perspective exploring cancer development and therapy |
topic | Micro (nano) plastics Carcinogenicity Drug carrier Cancer therapy |
url | https://doi.org/10.1186/s12943-025-02230-z |
work_keys_str_mv | AT xiangyingdeng themicronanoplasticsperspectiveexploringcancerdevelopmentandtherapy AT yajungui themicronanoplasticsperspectiveexploringcancerdevelopmentandtherapy AT linzhao themicronanoplasticsperspectiveexploringcancerdevelopmentandtherapy AT xiangyingdeng micronanoplasticsperspectiveexploringcancerdevelopmentandtherapy AT yajungui micronanoplasticsperspectiveexploringcancerdevelopmentandtherapy AT linzhao micronanoplasticsperspectiveexploringcancerdevelopmentandtherapy |